Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thaddeus R Tolleson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 17, 2002
Successful percutaneous coronary intervention with stent implantation in anomalous right coronary arteries arising from the left sinus of valsalva: a report of two casesMauricio G Cohen, Thaddeus R Tolleson, Robert H Peter, et al.
Journal of the American College of Cardiology|February 11, 2003
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trialThaddeus R Tolleson, J Conor O'Shea, John A Bittl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2007
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trialJean-Pierre Dery, Mark E Campbell, Jasmine Mathias, et al.
Journal of the American College of Cardiology|April 8, 2011
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trialAlan C Yeung, Martin B Leon, Ash Jain, et al.
The American Journal of Cardiology|July 31, 2003
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)Thaddeus R Tolleson, L Kristin Newby, Robert A Harrington, et al.
Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.
Journal of the American College of Cardiology|February 16, 2010
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialMartin B Leon, Laura Mauri, Jeffrey J Popma, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 17, 2002
Successful percutaneous coronary intervention with stent implantation in anomalous right coronary arteries arising from the left sinus of valsalva: a report of two casesMauricio G Cohen, Thaddeus R Tolleson, Robert H Peter, et al.
Journal of the American College of Cardiology|February 11, 2003
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trialThaddeus R Tolleson, J Conor O'Shea, John A Bittl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2007
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trialJean-Pierre Dery, Mark E Campbell, Jasmine Mathias, et al.
Journal of the American College of Cardiology|April 8, 2011
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trialAlan C Yeung, Martin B Leon, Ash Jain, et al.
The American Journal of Cardiology|July 31, 2003
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)Thaddeus R Tolleson, L Kristin Newby, Robert A Harrington, et al.
Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.
Journal of the American College of Cardiology|February 16, 2010
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialMartin B Leon, Laura Mauri, Jeffrey J Popma, et al.
Pageof 1